Sean M. Kerwin

Dr. Sean M. Kerwin

Department of Chemistry & Biochemistry, Texas State University, 601 University Dr. San Marcos, TX 78666, USA
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1997 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DSDaekyu Sun
Daekyu Sun
BTBrian Thompson
Brian Thompson
BCBrian E. Cathers
Brian E. Cathers
MSMiguel Salazar
Miguel Salazar
SKSean Kerwin
Sean Kerwin
LHLaurence H. Hurley
Laurence H. Hurley

15 August 1998 in Biochemistry
Verified
Journal Article
Closed access
OFOleg Yu. Fedoroff
Oleg Yu. Fedoroff
MSMiguel Salazar
Miguel Salazar
HHHaiyong Han
Haiyong Han
VCVioletta V. Chemeris
Violetta V. Chemeris
SKSean Kerwin
Sean Kerwin
LHLaurence H. Hurley
Laurence H. Hurley

1 December 2002 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
DKDevinder Kumar
Devinder Kumar
MJMelissa R Jacob
Melissa R Jacob
MRMichael B Reynolds
Michael B Reynolds
SKSean Kerwin
Sean Kerwin

1 March 2000 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SKSean Kerwin
Sean Kerwin
G-rich DNA sequences can adopt unusual four-stranded DNA structures, called G-quadruplex DNA. Variations in the molecularity, topology, strand orientation, and glycosidic conformation of the G-quadruplex DNA provide a diverse array of structures. Although G-quadruplex structures have only been observed in vitro, strong indirect evidence for their existence in vivo comes from the characterization of G-quadruplex DNA binding proteins, helicases, and nucleases. Telomeres are structures on the ends of chromosomes that are required for chromosomal stability. Telomeric DNA contains a single-stranded G-rich DNA overhang, which may adopt a G-quadruplex structure. Telomere shortening has been implicated in cellular senescence. Telomerase is an enzyme which synthesizes the G-rich strand of telomere DNA. Telomerase activity is highly correlated with cancer and may allow cancer cells to escape senescence. Based on these observations, telomerase has been proposed as a potential target for anticancer drug design. The targeting of telomerase is associated with potential problems, including the existence in some cancer cells of telomerase-independent mechanisms for telomere maintenance, and the long delay time between telomerase inhibition and effects on proliferation. One promising approach for inhibiting telomerase involves targeting the G-quadruplex DNA structures thought to be involved in telomere and telomerase function. Compounds that specifically bind G-quadruplex DNA may interact directly with telomeres, in addition to inhibiting telomerase, and produce more immediate antiproliferative effects. The diamidoanthraquinones, porphyrins, and perylene diimides have all been shown to bind G-quadruplex DNA and inhibit telomerase. Most of these compounds also bind double-stranded DNA and are cytotoxic at the concentrations required to inhibit telomerase; however, certain perylene diimides appear to be non-cytotoxic, G-quadruplex selective telomerase inhibitors. Biological characterization of such compounds may provide validation for the concept of the G-quadruplex as a target in drug design.

1 March 2000 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
LHLaurence H. Hurley
Laurence H. Hurley
RWRichard Wheelhouse
Richard Wheelhouse
DSDaekyu Sun
Daekyu Sun
SKSean Kerwin
Sean Kerwin
MSMiguel Salazar
Miguel Salazar
DHDaniel D. Von Hoff
Daniel D. Von Hoff

1 February 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MMMireya L. McKee
Mireya L. McKee
SKSean Kerwin
Sean Kerwin